These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23726764)

  • 41. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-β1b increases Th2 response in neuromyelitis optica.
    Nakajima H; Hosokawa T; Doi Y; Ikemoto T; Ishida S; Kimura F; Hanafusa T
    Int J Mol Sci; 2012 Sep; 13(10):12213-23. PubMed ID: 23202893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
    Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
    Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.
    Nakamura M; Misu T; Fujihara K; Miyazawa I; Nakashima I; Takahashi T; Watanabe S; Itoyama Y
    Mult Scler; 2009 Jun; 15(6):695-700. PubMed ID: 19435750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
    Chen Z; Feng F; Yang Y; Li J; Ma L
    Eur J Radiol; 2012 Nov; 81(11):3491-5. PubMed ID: 22445592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.
    Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G
    J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromyelitis optica - Devic's syndrome, update.
    Mandler RN
    Autoimmun Rev; 2006 Oct; 5(8):537-43. PubMed ID: 17027889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Devic's neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential.
    Cornelio DB; Braga RP; Rosa MW; Ayub AC
    Arch Gynecol Obstet; 2009 Sep; 280(3):475-7. PubMed ID: 19151993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
    Makino T; Ito S; Mori M; Yonezu T; Ogawa Y; Kuwabara S
    Mult Scler; 2013 Mar; 19(3):308-15. PubMed ID: 22809881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.
    Cabrera-Gómez JA; Quevedo-Sotolongo L; González-Quevedo A; Lima S; Real-González Y; Cristófol-Corominas M; Romero-García K; Ugarte-Sánchez C; Jordán-González J; de la Nuez JE; Lahera JG; Tellez R; Pedroso-Ibañez I; Roca RR; Cabrera-Núñez AY
    Mult Scler; 2007 Mar; 13(2):186-92. PubMed ID: 17439883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromyelitis optica: not a multiple sclerosis variant.
    Barnett MH; Sutton I
    Curr Opin Neurol; 2012 Jun; 25(3):215-20. PubMed ID: 22487568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
    Yoshida M
    Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
    Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
    BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuromyelitis optica and asian phenotype of multiple sclerosis.
    Kira J
    Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.